Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)
Condition: Pneumonia Childhood Intervention: Behavioral: Clinical Decision Support Sponsors: Vanderbilt University Medical Center; National Institute of Allergy and Infectious Diseases (NIAID); University of Pittsburgh Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Tocilizumab in Lung Transplantation
Condition: Lung Transplant Interventions: Drug: Tocilizumab; Drug: Placebo for Tocilizumab Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
Condition: HIV Interventions: Biological: N332-GT5 gp140 (IM, Bolus); Biological: N332-GT5 gp140 (IM, Fractioned); Biological: N332-GT5 gp140 (SC, Bolus); Biological: N332-GT5 gp140 (SC, Fractioned); Biological: SMNP (IM, Bolus); Biological: SMNP (IM, Fractioned); Biological: SMNP (S C, Bolus); Biological: SMNP (SC, Fractioned) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Department of Health and Human Services Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Evaluation of The Food Allergy Mastery Program
Condition: Food Allergy in Children Intervention: Behavioral: Food Allergy Mastery Program Sponsors: Children's National Research Institute; National Institute of Allergy and Infectious Diseases (NIAID); Northwestern University; Rhode Island Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Tocilizumab in Lung Transplantation
Condition: Lung Transplant Interventions: Drug: Tocilizumab; Drug: Placebo for Tocilizumab Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
Condition: HIV Interventions: Biological: N332-GT5 gp140 (IM, Bolus); Biological: N332-GT5 gp140 (IM, Fractioned); Biological: N332-GT5 gp140 (SC, Bolus); Biological: N332-GT5 gp140 (SC, Fractioned); Biological: SMNP (IM, Bolus); Biological: SMNP (IM, Fractioned); Biological: SMNP (S C, Bolus); Biological: SMNP (SC, Fractioned) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Department of Health and Human Services Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)
Condition: Pneumonia Childhood Intervention: Behavioral: Clinical Decision Support Sponsors: Vanderbilt University Medical Center; National Institute of Allergy and Infectious Diseases (NIAID); University of Pittsburgh Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Evaluation of The Food Allergy Mastery Program
Condition: Food Allergy in Children Intervention: Behavioral: Food Allergy Mastery Program Sponsors: Children's National Research Institute; National Institute of Allergy and Infectious Diseases (NIAID); Northwestern University; Rhode Island Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
Condition: HIV Interventions: Biological: N332-GT5 gp140 (IM, Bolus); Biological: N332-GT5 gp140 (IM, Fractioned); Biological: N332-GT5 gp140 (SC, Bolus); Biological: N332-GT5 gp140 (SC, Fractioned); Biological: SMNP (IM, Bolus); Biological: SMNP (IM, Fractioned); Biological: SMNP (S C, Bolus); Biological: SMNP (SC, Fractioned) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Department of Health and Human Services Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials
Tocilizumab in Lung Transplantation
Condition: Lung Transplant Interventions: Drug: Tocilizumab; Drug: Placebo for Tocilizumab Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials
Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)
Condition: Pneumonia Childhood Intervention: Behavioral: Clinical Decision Support Sponsors: Vanderbilt University Medical Center; National Institute of Allergy and Infectious Diseases (NIAID); University of Pittsburgh Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials
Tocilizumab in Lung Transplantation
Condition: Lung Transplant Interventions: Drug: Tocilizumab; Drug: Placebo for Tocilizumab Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
Condition: HIV Interventions: Biological: N332-GT5 gp140 (IM, Bolus); Biological: N332-GT5 gp140 (IM, Fractioned); Biological: N332-GT5 gp140 (SC, Bolus); Biological: N332-GT5 gp140 (SC, Fractioned); Biological: SMNP (IM, Bolus); Biological: SMNP (IM, Fractioned); Biological: SMNP (S C, Bolus); Biological: SMNP (SC, Fractioned) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Department of Health and Human Services Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials
Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)
Condition: Pneumonia Childhood Intervention: Behavioral: Clinical Decision Support Sponsors: Vanderbilt University Medical Center; National Institute of Allergy and Infectious Diseases (NIAID); University of Pittsburgh Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials